During the past decade, Centre Guillaume Le Conquerant conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Guillaume Le Conquerant" #1 sponsor was "Centre Francois Baclesse" with 3 trials, followed by "Groupe Oncologie Radiotherapie Tete et Cou" with 3 trials sponsored, "Institut Cancerologie de l'Ouest" with 2 trials sponsored, "UNICANCER" with 2 trials sponsored and "Centre Henri Becquerel" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Guillaume Le Conquerant" #1 collaborator was "National Cancer Institute, France" with 3 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "GORTEC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centre Guillaume Le Conquerant" are "Squamous Cell Carcinoma of the Head and Neck" (3 trials), "Lung Cancer" (2 trials), "Squamous Cell Carcinoma of Head and Neck" (2 trials), "Brain Metastasis" (1 trials) and "Breast Cancer Female" (1 trials). Many other conditions were trialed in "Centre Guillaume Le Conquerant" in a lesser frequency.

Most popular intervention types in "Centre Guillaume Le Conquerant" are "Drug" (10 trials), "Radiation" (10 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Radiotherapy" (3 trials), "Cisplatin" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Guillaume Le Conquerant" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Guillaume Le Conquerant". 1 are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centre Guillaume Le Conquerant, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Guillaume Le Conquerant, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".